Intraperitoneal administration of the MCHR1 antagonist SNAP-94847 was reported to significantly reverse anxiety- and depression-like behaviors induced by chronic stress (Smith et al., 2009; Kim et al., 2015). This evidence concerns the gene MCHR1 and major depressive disorder.